4.5 Article

Evaluation of a recently described risk classification scheme for pancreatic fistulae development after pancreaticoduodenectomy without routine post-operative drainage

Journal

HPB
Volume 16, Issue 11, Pages 987-993

Publisher

WILEY-BLACKWELL
DOI: 10.1111/hpb.12269

Keywords

-

Ask authors/readers for more resources

BackgroundPost-operative pancreatic fistula (POPF) formation occurs frequently after a pancreaticoduodenectomy (PD). Recently, a 10-point Fistula Risk Score (FRS) evaluating the likelihood of clinically relevant POPF (CR-POPF) development has been described and validated. This scheme has yet to be evaluated in PD patients managed without intra-operative drain placement. MethodsAmong patients undergoing PD at an academic centre since 2003, a retrospective analysis calculating FRS and its correlation with CR-POPF development was evaluated by logistic regression. Secondary analysis examined presentation and management of CR-POPF in undrained PD patients. ResultsFRS was calculated for 265 patients; 97.7% were managed without operative drains. The overall incidence of CR-POPF was 7.9%. Logistic regression revealed a 1.6-fold increase in CR-POPF risk per 1-point increase in FRS [95% confidence interval (CI) 1.2-2.0]. The negative predictive value in patients with FRS <3 was 100%, whereas the positive predictive value of FRS >6 was 16.7%. The median time to CR-POPF diagnosis was 18 days [interquartile range (IQR) 13-23]; 70.0% required readmission and 10.0% required a laparotomy. ConclusionsAmong patients without operative drainage, CR-POPF often has delayed presentations but most are managed non-operatively. The predictive value of high-risk FRS appears limited; conversely, a low-risk FRS accurately predicts the absence of CR-POPF and seems an appropriate metric for guiding care.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy

Thomas F. Seykora, Brett L. Ecker, Matthew T. McMillan, Laura Maggino, Joal D. Beane, Zhi Ven Fong, Robert H. Hollis, Nigel B. Jamieson, Ammar A. Javed, Stacy J. Kowalsky, John W. Kunstman, Giuseppe Malleo, Katherine E. Poruk, Kevin Soares, Vicente Valero, Lavanniya K. P. Velu, Ammara A. Watkins, Charles M. Vollmer, William E. Fisher, Mark P. Callery, Tara S. Kent, Michael G. House, Adam C. Berger, Christopher L. Wolfgang, Carlos Fernandez-del Castillo, Horacio J. Asbun, John A. Stauffer, Mark Bloomston, Ericka Haverick, Carl R. Schmidt, John D. Christein, Chad G. Ball, Elijah Dixon, Steven J. Hughes, Jeffrey A. Drebin, Michael Sprys, Amer H. Zureikat, Stephen W. Behrman, Claudio Bassi, Euan J. Dickson, Ronald R. Salem

ANNALS OF SURGERY (2019)

Article Gastroenterology & Hepatology

A Critical Appraisal of the July Effect: Evaluating Complications Following Pancreaticoduodenectomy

Timothy D. Murtha, John W. Kunstman, James M. Healy, Peter S. Yoo, Ronald R. Salem

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Editorial Material Oncology

Artificial Intelligence in Cancer Staging: Limitless Potential or Passing Fad?

John W. Kunstman

ANNALS OF SURGICAL ONCOLOGY (2020)

Article Surgery

Comprehensive Analysis of the Effect of Ketorolac Administration after Pancreaticoduodenectomy

John W. Kunstman, Whitney S. Brandt, Sara Abou Azar, Raymond A. Jean, Ronald R. Salem

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Article Surgery

Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival

Danielle R. Heller, Norman G. Nicolson, Nita Ahuja, Sajid Khan, John W. Kunstman

JAMA SURGERY (2020)

Article Oncology

Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database

Annabelle L. Fonseca, Deepa Cherla, Anai N. Kothari, Ching-Wei D. Tzeng, Martin J. Heslin, Krista R. Mehari, Fabian M. Johnston, Hop S. Tran-Cao

Summary: Medicaid expansion is associated with increased access to care processes and improved outcomes in PDAC patients. ME has helped to reduce disparities in PDAC treatment and outcomes in ME states.

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Author Reflections: The Challenge of Achieving High-Quality, Equitable Care for Pancreatic Cancer: Might Medicaid Expansion Be a Piece of the Puzzle?

Annabelle L. Fonseca, Fabian M. Johnston, Hop S. Tran-Cao

ANNALS OF SURGICAL ONCOLOGY (2021)

Editorial Material Oncology

ASO Visual Abstract: Disparities in Access to Oncologic Care in Pancreatic Cancer-A Systematic Review

Annabelle L. Fonseca, Hamza Khan, Krista R. Mehari, Deepa Cherla, Martin J. Heslin, Fabian M. Johnston

ANNALS OF SURGICAL ONCOLOGY (2022)

Editorial Material Oncology

ASO Visual Abstract: Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes-Evidence from the National Cancer Database

Annabelle L. Fonseca, Martin J. Heslin, Fabian M. Johnston, Hop S. Tran-Cao

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Oncology

Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review

Annabelle L. Fonseca, Hamza Khan, Krista R. Mehari, Deepa Cherla, Martin J. Heslin, Fabian M. Johnston

Summary: This article critically assesses and summarizes disparities in access to oncologic therapies for pancreatic cancer through a systematic review. The results show significant sociodemographic disparities in pancreatic cancer care, and multiple factors contribute to these disparities.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Surgical Resection of Colorectal Liver Metastases: Attitudes and Practice Patterns in the Deep South

Annabelle L. Fonseca, Isaac C. Payne, Sandra L. Wong, Marcus C. B. Tan

Summary: This study surveyed medical oncologists in the Deep South to understand attitudes and practice patterns regarding resectability and referral patterns for colorectal liver metastases. The results showed wide variations in perceptions of resectability and referral patterns among medical oncologists, indicating a need for wider dissemination of resectability criteria and more involvement of liver surgeons in the management of patients with colorectal liver metastases.

JOURNAL OF GASTROINTESTINAL SURGERY (2022)

Article Multidisciplinary Sciences

Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma

Yasheen Gao, Melinda Wang, Xiaojia Guo, Joanna Hu, Tian-min Chen, Sade M. B. Finn, Jill Lacy, John W. Kunstman, Charles H. Cha, Melena D. Bellin, Marie E. Robert, Gary Desir, Fred S. Gorelick

Summary: Dysregulated renalase expression in PDAC tissues and its corresponding plasma levels are associated with advanced tumor characteristics, decreased overall survival, and reduced resectability in patients with locally advanced/borderline resectable PDAC.

PLOS ONE (2021)

Article Surgery

Access to telehealth services for colorectal cancer patients in the United States during the COVID-19 pandemic

Victoria A. Marks, Walter R. Hsiang, Waez Umer, Afash Haleem, Dana Kim, John W. Kunstman, Michael S. Leapman, Kevin M. Schuster

Summary: This study examines the availability of telehealth for colorectal cancer patients in a national sample of accredited hospitals during the COVID-19 pandemic. It identifies predictive factors for telehealth availability and highlights the need to consider these factors when formulating telehealth policies.

AMERICAN JOURNAL OF SURGERY (2022)

Editorial Material Surgery

Pancreatic operative experience for residents: How much is enough?

Annabelle L. Fonseca, Martin J. Heslin

AMERICAN JOURNAL OF SURGERY (2023)

Article Surgery

Radiation and Its Impact on Local Recurrence in Extremity and Trunk Well-Differentiated Liposarcomas

Annabelle L. Fonseca, Christina L. Roland, Janice N. Cormier, Keila E. Torres, Kelly H. Hunt, Andrew J. Bishop, Ashleigh Guadagnolo, Barry W. Feig

AMERICAN SURGEON (2019)

No Data Available